Navigation Links
RAFT polymerization technology enabling the biotech industry
Date:4/21/2013

CSIRO and Mirus Bio LLC are pleased to announce a new license arrangement that will enable Mirus Bio to utilize the unique characteristics of CSIRO's Reversible Addition-Fragmentation chain Transfer polymerisation technology (RAFT) to expand upon its high-end polymer development capabilities for the biotech industry.

Mirus Bio Vice President of Scientific Operations Scott Hayes said the agreement would allow the company to broaden its expertise.

"This agreement with CSIRO broadens the scope of specialised polymer design tools available to Mirus and facilitates our continued efforts to improve nucleic acid transfer capabilities. We expect that utilization of RAFT will lead to new discoveries and expedite our product development efforts," Dr Hayes said.

"CSIRO is very pleased to be working with Mirus Bio in the transfection space," said Cathy Foley from CSIRO.

"The scientists at Mirus are leaders in introducing innovative products in this area and have developed a range of delivery technologies for researchers in the biotech industry that can make use of our polymer technology," she said.

"RAFT has very broad applicability in the biotech and biomedical industry because of the need for new and improved multifunctional polymers for many different applications. RAFT enables the rapid, rational design and prove-out of bespoke macromolecules," Dr Foley said.


'/>"/>

Contact: Samantha Carroll
Sam.Carroll@csiro.au
61-395-452-436
CSIRO Australia
Source:Eurekalert

Page: 1

Related biology news :

1. Labor der Zukunft -- Tomorrows laboratory technology
2. The future of plant science - a technology perspective
3. The future of plant science a technology perspective
4. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
5. UF researchers look for ways to make an emerging technology safe for environment
6. Breast cancer risk gene discovery fast tracked by new technology
7. Obese patients face higher radiation exposure from CT scans -- but new technology can help
8. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
9. Powerful sequencing technology decodes DNA folding pattern
10. New technology tracks sparrow migration for first time from California to Alaska
11. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/7/2017)... BRIGHTON, England , March 7, 2017 Brandwatch ... been chosen by The Prince,s Trust to uncover insights ... insights across The Trust. The UK,s leading youth charity ... track social campaign results and get a better understanding of the ... ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December 2016 ... extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific ... offer NAT screening for blood donors under an Investigational New Drug (IND) study protocol. ...
(Date:4/26/2017)...  Genisphere LLC, provider of the 3DNA ® ... and sponsored research agreement with the University of ... overall goal of the partnership is to study ... and formulations after in vivo administration. ... as well as inflammatory responses, demonstrating various methods ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
Breaking Biology Technology: